Jiabin B. Zheng
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 60 publications
Short- and long-term outcomes after laparoscopic versus open total gastrectomy for stage 0-I gastric cancer: a multicenter, retrospective analysis.
Journal: Chinese clinical oncology
Published: April 13, 2026
Short- and long-term outcomes after laparoscopic versus open total gastrectomy for stage 0-I gastric cancer: a multicenter, retrospective analysis.
Journal: Chinese clinical oncology
Published: October 31, 2025
Prospective evaluation of radical surgery for adenocarcinoma of oesophagogastric junction: real-world insights from the CLAEG study.
Journal: Gut
Published: October 27, 2025
Engineered oncolytic virus armed with anti-PCSK9 scFv boosts long-term CD8+ T cell immunity via rewiring MHC-I antigen presentation.
Journal: Cell reports. Medicine
Published: October 10, 2025
Impact of prior cancer history on survival in patients with adenocarcinoma of esophagogastric junction: a retrospective cohort study using SEER database.
Journal: Translational cancer research
Published: September 19, 2025
Aging and increased cancer risk: exploring the potential of LE8 score to mitigate risk.
Journal: npj aging
Published: August 24, 2025
Stenotrophomonas promotes gastrointestinal tumor progression via STING degradation in tumour cells and mitigated immune response.
Journal: Nature communications
Published: July 13, 2025
Association of healthy lifestyle behaviors with incident gastroesophageal reflux disease in a large population-based prospective cohort.
Journal: Preventive medicine reports
Published: June 26, 2025
Correction: Associations Between Chronotype, Genetic Susceptibility and Risk of Colorectal Cancer in UK Biobank.
Journal: Journal of epidemiology and global health
Published: June 10, 2025
Targeting DOT1L Reactivates HERV-K to Drive Cell-Autonomous and Paracrine Senescence in Adenocarcinoma of the Esophagogastric Junction.
Journal: Cancer research
Published: June 08, 2025
EZH2 inhibition and 5-azacytidine enhance antitumor immunity in PTEN-deficient glioblastoma by activation viral mimicry response.
Journal: Journal for immunotherapy of cancer
Published: May 24, 2025
Targeting TBK1 potentiates oncolytic virotherapy via amplifying ICAM1-mediated NK cell immunity in chemo-resistant colorectal cancer.
Journal: Journal for immunotherapy of cancer
Published: May 16, 2025
Last Updated: 09/26/2026